Electrocardiographic Prognostic Marker in Pulmonary Arterial Hypertension: RS Time

被引:0
作者
Koyun, Emin [1 ]
Sahin, Anil [2 ]
Yilmaz, Ahmet [3 ]
Dindas, Ferhat
Cerik, Idris Bugra [4 ]
Koyun, Gorkem Berna [5 ]
机构
[1] Sivas Numune Hosp, Dept Cardiol, TR-58000 Sivas, Turkiye
[2] Sivas Cumhuriyet Univ Hosp, Dept Cardiol, Sivas, Turkiye
[3] Usak Univ, Training & Res Hosp, Dept Cardiol, Usak, Turkiye
[4] Ordu Univ, Training & Res Hosp, Dept Cardiol, Ordu, Turkiye
[5] Sivas Cumhuriyet Univ Hosp, Dept Chest Dis, Sivas, Turkiye
关键词
Electrocardiography; Prognosis; Pulmonary Hypertension; RIGHT VENTRICLE; EXERCISE; OUTCOMES;
D O I
10.36660/abc.20240083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension is a condition that involves the remodeling of the right ventricle. Ongoing remodeling is also associated with disease prognosis. During the restructuring process, complex changes such as hypertrophy and dilatation may also be reflected in electrocardiographic parameters. Objectives: Our study aimed to investigate the relationship between prognosis and electrocardiographic parameters in patients with pulmonary arterial hypertension. Methods: The study was designed retrospectively and included patients diagnosed with pulmonary arterial hypertension between 2010 and 2022. The patients were divided into two groups based on their survival outcome. Various parameters, including electrocardiographic, demographic, echocardiographic, catheter, and blood parameters, were compared between the two groups. A p-value of <0.05 was considered statistically significant. Results: In the multivariate Cox analyses, the parameters that were found to be independently associated with survival were the 6-minute walk test, mean pulmonary artery pressure, presence of pericardial effusion, and time between the beginning of the QRS and the peak of the S wave (RS time) (p<0.05 for each). Of all the parameters, RS time demonstrated the best diagnostic performance (AUC:0.832). In the survival analysis, a significant correlation was found between RS time and survival when using a cut-off value of 59.5 ms (HR: 0.06 [0.02-0.17], p < 0.001). Conclusions: According to the results of our study, a longer RS time is associated with poor prognosis in patients with pulmonary arterial hypertension. We can obtain information about the course of the disease with a simple, non-invasive parameter.
引用
收藏
页数:9
相关论文
共 26 条
  • [1] An Alternative Echocardiographic Method to Estimate Mean Pulmonary Artery Pressure: Diagnostic and Clinical Implications
    Aduen, Javier F.
    Castello, Ramon
    Lozano, Marcelo M.
    Hepler, George N.
    Keller, Cesar A.
    Alvarez, Francisco
    Safford, Robert E.
    Crook, Julia E.
    Heckman, Michael G.
    Burger, Charles D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (07) : 814 - 819
  • [2] Echocardiography in Pulmonary Arterial Hypertension
    Ferrara, Francesco
    Zhou, Xiao
    Gargani, Luna
    Wierzbowska-Drabik, Karina
    Vriz, Olga
    Fadel, Bahaa M.
    Stanziola, Anna Agnese
    Kasprzak, Jaroslaw
    Vannan, Mani
    Bossone, Eduardo
    [J]. CURRENT CARDIOLOGY REPORTS, 2019, 21 (04)
  • [3] Step climbing capacity in patients with pulmonary hypertension
    Fox, Benjamin Daniel
    Langleben, David
    Hirsch, Andrew
    Boutet, Kim
    Shimony, Avi
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (01) : 51 - 61
  • [4] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (01) : 67 - +
  • [5] A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
    Galie, Nazzareno
    Manes, Alessandra
    Negro, Luca
    Palazzini, Massimiliano
    Bacchi-Reggiani, Maria Letizia
    Branzi, Angelo
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 (04) : 394 - 403
  • [6] Morphologic and Functional Remodeling of the Right Ventricle in Pulmonary Hypertension by Real Time Three Dimensional Echocardiography
    Grapsa, Julia
    Gibbs, J. Simon R.
    Dawson, David
    Watson, Geoffrey
    Patni, Ravi
    Athanasiou, Thanos
    Punjabi, Prakash P.
    Howard, Luke S. G. E.
    Nihoyannopoulos, Petros
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (06) : 906 - 913
  • [7] The predictive value of RS time for short term mortality in patients with acute pulmonary embolism
    Gumusdag, Ayca
    Burak, Cengiz
    Suleymanoglu, Muhammed
    Yesin, Mahmut
    Tanik, Veysel Ozan
    Karabag, Yavuz
    Cagdas, Metin
    Rencuzogullari, Ibrahim
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2020, 62 : 94 - 99
  • [8] Comprehensive network analysis to identify the molecular pathogenesis of pulmonary hypertension
    Hasan, Bilal
    Tuyghun, Ehbal
    Yang, Yan
    Tuerxun, Paerhati
    Li, Xiufen
    [J]. MINERVA CARDIOANGIOLOGICA, 2020, 68 (04): : 319 - 325
  • [9] Humbert M, 2023, EUR RESPIR J, V61, DOI [10.1183/13993003.00879-2022, 10.1093/eurheartj/ehac237]
  • [10] Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension
    Kovacs, Gabor
    Avian, Alexander
    Foris, Vasile
    Tscherner, Maria
    Kqiku, Xhylsime
    Douschan, Philipp
    Bachmaier, Gerhard
    Olschewski, Andrea
    Matucci-Cerinic, Marco
    Olschewski, Horst
    [J]. PLOS ONE, 2016, 11 (12):